Malignant head and neck paragangliomas: Is there an optimal treatment strategy?

Head and Neck Oncology

Volumn 2, Issue 1, 2010, Pages

  Moskovic, Daniel J ^a,b   Smolarz, Joseph R ^c   Stanley, Douglas ^c   Jimenez, Camilo ^c   Williams, Michelle D ^c   Hanna, Ehab Y ^c   Kupferman, Michael E ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b The Sanford C Bernstein Co Center for Leadership and Ethics   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LOMUSTINE; MESNA; VINCRISTINE;

ADOLESCENT; ADULT; ALOPECIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; NEUTROPENIA; PARAGANGLIOMA; PRIORITY JOURNAL; PROGNOSIS; TREATMENT RESPONSE; ALGORITHM; CALIBRATION; CLINICAL PROTOCOL; COHORT ANALYSIS; EVALUATION; HEAD AND NECK TUMOR; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RETROSPECTIVE STUDY; STANDARD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ALGORITHMS; CALIBRATION; CLINICAL PROTOCOLS; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PARAGANGLIOMA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77958111146     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: 10.1186/1758-3284-2-23     Document Type: Article

References (18)

1. Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas. RD Klein L Jin K Rumilla WF Young Jr RV Lloyd, Diagn Mol Pathol 2008 17 94 100 10.1097/PDM.0b013e318150d67c 18382370
2. Chemodectoma (non-chromaffinic paraganglioma) of the carotid body with distant metastases; with illustrative case. R Romanski, Am J Pathol 1954 30 1 13 13124456
3. Malignant paraganglioma - a case report and literature review. GH Branham DR Gnepp S O'McMenomey WH Friedman, Otolaryngol Head Neck Surg 1989 101 99 103 2502767
4. National Cancer Data Base report on malignant paragangliomas of the head and neck. JH Lee F Barich LH Karnell,, et al. Cancer 2002 94 730 737 10.1002/cncr.10252 11857306
5. Paragangliomas of the head and neck. ME Kupferman EY Hanna, Curr Oncol Rep 2008 10 156 161 10.1007/s11912-008-0024-9 18377829
6. Malignant glomus tumors. S Manolidis JA Shohet CG Jackson ME Glasscock, Laryngoscope 1999 109 30 34 10.1097/00005537-199901000-00007 9917036
7. Tumors of the carotid body: Clinical and pathologic considerations of twenty tumors affecting nineteen patients (one bilateral). SW Harrington OT Clagett MB Dockerty, Ann Surg 1941 114 820 833 10.1097/00000658-194111000-00003 17857913
8. Malignant Glomus vagale: report of a case and review of the literature. NS Druck GJ Spector RH Ciralsky JH Ogura, Arch Otolaryngol 1976 102 534 536 184772
9. Paragangliomas: etiology, presentation, and management. KE Joynt JJ Moslehi KL Baughman, Cardiol Rev 2009 17 159 164 10.1097/CRD.0b013e3181a6de40 19525677
10. A 15-year experience with chemotherapy of patients with paraganglioma. SR Patel DJ Winchester RS Benjamin, Cancer 1995 76 1476 1480 10.1002/1097- 0142(19951015)76:8<1476::AID-CNCR28207608273.0.CO;2-9 8620426
11. Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients. H Huang J Abraham E Hung,, et al. Cancer 2008 113 2020 2028 10.1002/cncr.23812 18780317
12. Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG). PA Fitzgerald RE Goldsby JP Huberty,, et al. Ann N Y Acad Sci 2006 1073 465 490 10.1196/annals.1353.050 17102115
13. Functional imaging as an aid to decision-making in metastatic paraganglioma. JB Bomanji SW Hyder MN Gaze,, et al. Br J Radiol 2001 74 266 269 11338105
14. Scintigraphic localization of pheochromocytoma. JC Sisson MS Frager TW Valk,, et al. N Engl J Med 1981 305 12 17 10.1056/NEJM198107023050103 7231514
15. Radiation therapy of metastatic pheochromocytoma: case report and review of the literature. L Yu AM Fleckman M Chadha E Sacks C Levetan B Vikram, Am J Clin Oncol 1996 19 389 393 10.1097/00000421-199608000-00015 8677912 (Pubitemid 26242239)
16. Malignant paraganglioma with skeletal metastases and spinal cord compression: response and palliation with chemotherapy. WC Mertens DJ Grignon W Romano, Clin Oncol (R Coll Radiol) 1993 5 126 128 7683202
17. Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes? C Jimenez G Cote A Arnold RF Gagel, J Clin Endocrinol Metab 2006 91 2851 2858 10.1210/jc.2005-2178 16735498
18. A diagnostic and therapeutic approach to paragangliomas of the larynx. KW Sanders F Abreo E Rivera FJ Stucker CO Nathan, Arch Otolaryngol Head Neck Surg 2001 127 565 569 11346434